|
DYN Dyne Therapeutics Inc 1818794 |
| Balance Sheet |
|
Current Assets
|
736,390,000 |
|
Assets
|
768,844,000 |
|
Current Liabilities
|
43,260,000 |
|
Liabilities
|
63,304,000 |
|
Equity
|
705,540,000 |
|
Shares Out
|
100,401,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-208,034,000 |
|
Investing Cash Flow
|
-188,066,000 |
| Market Analysis |
Market Cap
|
3,501,976,523 |
|
BVPS
|
7.03 |
|
PB
|
4.02 |
|
EPS
|
-3.58 |
|
PS
|
3.44 |
|
FCF
|
-396,100,000 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/31 |
|
11/12 |
-0.96 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DYN documents filed with the SEC.
DYN Filings
Clear
